Multipurpose Prevention Approaches with Antiretroviral-Based Formulations

We compared the preclinical safety and efficacy of tenofovir (TFV) 1% gel with that of MZC gel [containing 50 μM MIV-150, 14 mM Zn(O(2)CCH(3))(2)(H(2)O)(2), and 3% carrageenan] through a series of in vitro, ex vivo, and in vivo assays. The two gels showed good antiviral therapeutic indexes (50% cyto...

Descripción completa

Detalles Bibliográficos
Autores principales: Jean-Pierre, Ninochka, Barnable, Patrick, Kizima, Larisa, Rodríguez, Aixa, Seidor, Samantha, Cooney, Michael L., Clark, Meredith R., Doncel, Gustavo F., Robbiani, Melissa, Zydowsky, Thomas M., Teleshova, Natalia, Fernández-Romero, José A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2016
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750675/
https://www.ncbi.nlm.nih.gov/pubmed/26596943
http://dx.doi.org/10.1128/AAC.02468-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750675/
https://www.ncbi.nlm.nih.gov/pubmed/26596943
http://dx.doi.org/10.1128/AAC.02468-15

Ejemplares similares